42 Worksheets on Vial Mixing/Preparation with Answers
This chapter contains worksheets with examples of vial mixing prescriptions using testing results from hypothetical patients, which are similar to what a practitioner might actually encounter in practice. There are examples of 5 mL vials created for subcutaneous immunotherapy (SCIT), vials created for sublingual immunotherapy (SLIT), and an oral mucosal immunotherapy (OMIT) example. If a practitioner is new to the practice of allergy, he/she may find these worksheets very helpful in testing knowledge or practicing what have been learned so far. Each worksheet is accompanied by a corresponding answer sheet. Enjoy!
For SCIT, some practitioners will determine an endpoint and some will not. An endpoint is not necessary to initiate SCIT or create a vial prescription. However, these worksheets can provide some practice for those who do like to or are interested in learning about endpoints.
Intradermal Dilutional Testing Vial Mixing Case Version 1
Below are the IDT testing results of a hypothetical patient. Determine an endpoint, and then using that endpoint, create a 5-mL vial mix prescription for the patient’s first injection vial for SCIT. In this version, 50% glycerin is used to maintain the potency of vial as (PNS) is being used as the diluent.
Intradermal Dilutional Testing Vial Mixing Case Version 1 (Answers)
Below are the answers for the IDT testing results of a hypothetical patient, including the endpoints and starting dilutions for the patient’s first injection vial for SCIT. This vial is 5 mL in size, but similar math could be used to create a 10-mL vial. In this version, 50% glycerin is used to maintain the potency of vial as PNS is being used as the diluent. In order to maintain potency, the vial must contain at least 1 mL of 50% glycerin.
Intradermal Dilutional Testing Vial Mixing Case Version 2
▶Table 42.1 shows the IDT testing results of a hypothetical patient. Determine an endpoint, and then using that endpoint, create a 5-mL vial mix prescription for the patient’s first injection vial for SCIT. In this version, HSA is used as the diluent to maintain potency of the vial.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
